ResApp Receives Notice of Acceptance for Core Patent in Australia

View printer-friendly version Brisbane, Australia, 15 August 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that IP...

ResApp Completes Enrolment in Australian Paediatric Clinical Study

View printer-friendly version Brisbane, Australia, 2 August 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce the completion...

ResApp Completes Enrolment in SMARTCOUGH-C-2 Study

View printer-friendly version Brisbane, Australia, 1 August 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce the completion...